UPC_APP_12137/2024

Order of the Court of Appeal (Panel 2) on an application by Curio Bioscience Inc. for restriction of access to confidential information under Rule 262A RoP. Curio sought to limit access to an unredacted document (CR-3) in the context of a pending language-change appeal. The Court held that a first-instance Rule 262A order restricting access to certain documents retains its force during appeal proceedings even if not directly challenged on appeal, and continues to govern access until the conclusion of the entire proceedings. Access to the confidential document was maintained restricted to specified persons.

The Court of Appeal (Second Panel) ruled that the confidentiality order issued by the Düsseldorf Local Division on 11 March 2024 under R. 262A RoP (restricting access to document CR-3) continues to apply in the appeal proceedings, making Curio Bioscience's separate request for a confidentiality protection order in the appeal superfluous. The existing order covers 'outside these proceedings' broadly, including the appeal. No new order needed.